RxFinder RxPBMPharmaBenefitsRxSaverRxNewsMedicalClaimRxInsiderClinicalRx
A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate (Beyaz)

First FDA approval2010-10-07
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$1.43/unit
3 NDCs benchmarked, lowest of all strengths.
Average NADAC
$4.32
Across all dosage forms in distribution.
Highest NADAC
$8.29
Wide spread — brand-strength NDCs still in market.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema8 entries indexed · 4 visible
What is Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate used for?

Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate is a this drug class medication tracked in Medicare Part D.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is there a generic for Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate?

No. Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate is brand-only with no generic equivalents currently in market.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
How much does my plan pay for Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate?

Across 329 Part D plans, Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate averages $4.32/unit (NADAC). Lowest available: $1.43/unit. Highest in distribution: $8.29/unit.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate on the FDA shortage list?

No. Drospirenone/Ethinyl Estradiol/Levomefolate and Levomefolate is not currently on the FDA Drug Shortage Database.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.